EVP&CFO Garis Douglas Michael bought 1,300 shares of CTEV at $17.69; 5 of 5 prior buys at this ticker well-timed at 90-day mark, yet stock down 75.8% from 52-week high.
Garis Douglas Michael's purchase of 1,300 shares at $17.69 follows a striking pattern: his prior 5 open-market buys at Claritev all delivered positive 90-day returns (ranging from +84.6% to +158.8%), indicating consistent skill in entry timing at this specific ticker. His cross-ticker track record is similarly impressive, with 8 prior buys averaging +789.9% over 90 days and a 100.00% win rate. However, context demands caution: the stock is now -75.8% from its 52-week high and -23.4% in just 30 days, Claritev reported net income of $-69.8M on revenue of $246.0M, and the company remains unprofitable on a full-year basis. This buy occurs within a 14-day cluster involving 2 other insiders, suggesting coordinated action, yet the fundamental backdrop—steep price decline, operating losses, and severely depressed valuation (P/E of 0.29)—makes this transaction a test of whether prior timing success extends into a deteriorating business environment.